Work

Phase 2 study to evaluate palbociclib in combination with irinotecan and temozolomide in pediatric patients with recurrent or refractory Ewing sarcoma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.tps11583

Authors: Theodore Willis Laetsch, Katherine A. Janeway, Douglas S. Hawkins, Katarzyna Juszczak-Kosela, Jodi Ann Muscal, Anderson B. Collier

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania, Dana-Farber Cancer Institute, Seattle Children's Hospital, University of Washington, Fred Hutch Cancer Center, Baylor College of Medicine, University of Mississippi Medical Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer

OpenAlex ID: W4286293090

Cites:

Cited by: 1

Related to: 10